- Reaction score
- 14
Can’t post as I’m a new member, but results are on their website.
Thoughts anyone?
Thoughts anyone?
The top line results of the planned six-month interim analysis for the phase II dose ranging study for Clascoterone (Breezula®) solution in androgenic alopecia in men demonstrated statistically significant improvement for Target Area Hair Count (TAHC) and directional improvement for Hair Growth Assessment (HGA).
No comparison to Finasterid or Min
So they didn’t use the verbiage you wanted them to in their one sentence summary?The top line results of the planned six-month interim analysis for the phase II dose ranging study for Clascoterone (Breezula®) solution in androgenic alopecia in men demonstrated statistically significant improvement for Target Area Hair Count (TAHC) and directional improvement for Hair Growth Assessment (HGA).
No comparison to Finasterid or Min
That time of year where we all get hyped for a presentation only to get disappointed. Hope it's different this time.
https://www.thieme-connect.de/produ...?device=mobile&innerWidth=393&offsetWidth=393
It's stronger than finasteride. That much has been established
Write - when we already know that it is twice as effektive as finasteride, for what are we waiting then?
Maybe the release date or what answers do you need from this Phase?
Arzneimittelforschung 2004; 54(12): 881-886
DOI: 10.1055/s-0031-1297043
Wow - we knew that 15 years ago and it still takes 3 more years until Release of the medicamantion?